Skyrocketing Pharmaceutical Imports to the U.S. Endanger National Security
U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge.
U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge.
A Department of Energy official warns that China’s outsized role in the solar industry is a headwind for Biden’s green energy plans, and energy security.
The November trade deficit fell, but that didn’t stop the U.S. from record imports this year. The goods deficit is now over $1.1 trillion.
Online retailers don’t have to post where their products are made. Country of Origin labeling online would help people find US alternatives to imports.
A Senate Commerce subcommittee hearing heard from witnesses who said worker shortages will ultimately be a drag on U.S. reshoring efforts. Pharmaceutical reps warned of high energy costs, which could add to import dependence.
As 2022 winds down, one thing remains clear, globalization is losing support among policy makers, and even among influencers like Paul Krugman.
The government’s latest trade figures show a surge in imports, even as the economy runs the risk of recession. A look at October trade flows.
China’s Zero Covid protests should persuade Washington, businesses, and consumers that dependence on China for manufacturing American goods will dull the shine off iconic American brands. Political risks are rising.
CPA Committee member Michael Collins looks at what made globalization what it is today and considers the big money barriers to rolling it back.
CPA chief economist Jeff Ferry took on a Pepperdine University free trader in a firey debate this week.